The European Medicines Agency will review GSK's request to approve its asthma drug Nucala as an additional treatment for ...
The European Medicines Agency (EMA) has agreed to review GSK’s application of expanding Nucala’s (mepolizumab) use as add-on ...
Patients with COPD plus a depression/anxiety disorder had poorer scores related to disease burden and health-related quality of life, according to data published in Chronic Obstructive Pulmonary ...
EMA accepts for review GSK’s application to expand use of Nucala for COPD treatment: London, UK Wednesday, March 26, 2025, 11:00 Hrs [IST] GSK plc announced that the European Me ...
Adults with arthritis and chronic obstructive pulmonary disease (COPD) have a higher risk for mortality than individuals without COPD.
The systemic immune response index outperformed other inflammatory markers in predicting chronic obstructive pulmonary ...
People with chronic obstructive pulmonary disease (COPD) and arthritis have a higher risk of death than people with arthritis ...
Adults who had an above-average BMI, overweight or obesity during childhood have increased risk for developing chronic ...
Genetic factors may affect the functional status of patients with chronic obstructive pulmonary disease (COPD).
A new study links childhood overweight and obesity to higher COPD risk, stressing early weight management for lung health.
Many people with COPD have other conditions like diabetes or high cholesterol, too. Managing several conditions can be ...
The global COPD and asthma diagnostic and monitoring device market accounted for $4,953.60 million in 2019, and is expected to reach $8,202.62 million by 2027, registering a CAGR of 6.3% from 2020 to ...